OxamisoleAlternative Names: PR 879317A
Latest Information Update: 07 Nov 1994
At a glance
- Originator Fisons
- Class Imidazoles; Pyridines; Small molecules
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 07 Nov 1994 Discontinued-I for Viral infections in USA (Unknown route)